International Biotechnology Trust as of Dec. 31, 2017
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 65 positions in its portfolio as reported in the December 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biogen Idec (BIIB) | 7.3 | $21M | 65k | 318.58 | |
| Celgene Corporation | 7.0 | $20M | 190k | 104.37 | |
| Regeneron Pharmaceuticals (REGN) | 5.4 | $15M | 41k | 376.05 | |
| Nektar Therapeutics (NKTR) | 4.4 | $13M | 211k | 59.70 | |
| Exelixis (EXEL) | 4.4 | $13M | 410k | 30.39 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.0 | $11M | 75k | 149.88 | |
| Adamas Pharmaceuticals | 3.8 | $11M | 315k | 33.87 | |
| ACADIA Pharmaceuticals (ACAD) | 3.5 | $10M | 334k | 30.10 | |
| Gilead Sciences (GILD) | 3.1 | $8.8M | 123k | 71.65 | |
| Alexion Pharmaceuticals | 3.0 | $8.7M | 72k | 119.61 | |
| Sage Therapeutics (SAGE) | 3.0 | $8.5M | 52k | 164.69 | |
| Entellus Medical Cm | 2.9 | $8.3M | 342k | 24.38 | |
| D Stemline Therapeutics | 2.7 | $7.7M | 493k | 15.60 | |
| Incyte Corporation (INCY) | 2.4 | $6.9M | 73k | 94.72 | |
| Tesaro | 2.3 | $6.4M | 77k | 82.87 | |
| Amgen (AMGN) | 2.2 | $6.3M | 36k | 173.91 | |
| BioMarin Pharmaceutical (BMRN) | 2.1 | $6.1M | 68k | 89.16 | |
| Array BioPharma | 2.1 | $6.1M | 478k | 12.80 | |
| Halozyme Therapeutics (HALO) | 2.0 | $5.7M | 283k | 20.25 | |
| Clovis Oncology | 1.8 | $5.2M | 76k | 68.00 | |
| Shire | 1.7 | $4.8M | 31k | 155.10 | |
| Alnylam Pharmaceuticals (ALNY) | 1.6 | $4.7M | 37k | 127.04 | |
| Paratek Pharmaceuticals | 1.6 | $4.5M | 254k | 17.90 | |
| Ligand Pharmaceuticals In (LGND) | 1.4 | $4.0M | 29k | 136.93 | |
| Bluebird Bio (BLUE) | 1.3 | $3.6M | 20k | 178.00 | |
| Synergy Pharmaceuticals | 1.2 | $3.4M | 1.5M | 2.23 | |
| Kalvista Pharmaceuticals (KALV) | 1.1 | $3.1M | 322k | 9.73 | |
| Seattle Genetics | 1.1 | $3.1M | 58k | 53.51 | |
| Sangamo Biosciences (SGMO) | 1.1 | $3.0M | 185k | 16.40 | |
| Dermira | 1.1 | $3.0M | 108k | 27.81 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $2.9M | 37k | 77.59 | |
| Ionis Pharmaceuticals (IONS) | 0.9 | $2.6M | 52k | 50.27 | |
| Five Prime Therapeutics | 0.9 | $2.5M | 116k | 21.91 | |
| Molecular Templates | 0.9 | $2.5M | 248k | 10.00 | |
| Foamix Pharmaceuticals | 0.8 | $2.3M | 383k | 6.01 | |
| Juno Therapeutics | 0.8 | $2.3M | 50k | 45.68 | |
| Madrigal Pharmaceuticals (MDGL) | 0.8 | $2.3M | 25k | 91.72 | |
| Achaogen | 0.8 | $2.2M | 205k | 10.74 | |
| Avexis | 0.7 | $1.9M | 17k | 110.65 | |
| Deciphera Pharmaceuticals (DCPH) | 0.6 | $1.7M | 77k | 22.68 | |
| Transenterix | 0.6 | $1.7M | 889k | 1.92 | |
| Anaptysbio Inc Common (ANAB) | 0.6 | $1.7M | 17k | 100.65 | |
| Sarepta Therapeutics (SRPT) | 0.5 | $1.5M | 27k | 55.63 | |
| Fibrogen (FGEN) | 0.5 | $1.5M | 31k | 47.39 | |
| Merus Nv | 0.5 | $1.4M | 75k | 18.82 | |
| Cymabay Therapeutics | 0.5 | $1.3M | 145k | 9.20 | |
| Gw Pharmaceuticals Plc ads | 0.5 | $1.3M | 9.6k | 131.98 | |
| Optinose (OPTN) | 0.4 | $1.2M | 65k | 18.89 | |
| Puma Biotechnology (PBYI) | 0.4 | $1.2M | 12k | 98.83 | |
| Portola Pharmaceuticals | 0.4 | $1.2M | 24k | 48.67 | |
| Enteromedics | 0.4 | $1.2M | 788k | 1.46 | |
| Agios Pharmaceuticals (AGIO) | 0.4 | $1.1M | 20k | 57.15 | |
| Horizon Pharma | 0.3 | $1.0M | 69k | 14.59 | |
| Spring Bk Pharmaceuticals In | 0.3 | $956k | 73k | 13.10 | |
| Beigene (BGNE) | 0.3 | $928k | 9.5k | 97.68 | |
| Aerie Pharmaceuticals | 0.3 | $883k | 15k | 59.75 | |
| Amicus Therapeutics (FOLD) | 0.3 | $843k | 59k | 14.39 | |
| Supernus Pharmaceuticals (SUPN) | 0.3 | $834k | 21k | 39.80 | |
| G1 Therapeutics (GTHX) | 0.3 | $773k | 39k | 19.82 | |
| Omeros Corporation (OMER) | 0.2 | $660k | 34k | 19.41 | |
| Spark Therapeutics | 0.2 | $617k | 12k | 51.42 | |
| Radius Health | 0.2 | $597k | 19k | 31.76 | |
| Prothena (PRTA) | 0.2 | $562k | 15k | 37.47 | |
| Xencor (XNCR) | 0.1 | $395k | 18k | 21.94 | |
| Viking Therapeutics (VKTX) | 0.1 | $284k | 70k | 4.06 |
